#BEGIN_DRUGCARD DB02580

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1191-87-3

# ChEBI_ID:
44934

# Chemical_Formula:
C12H26O6

# Chemical_IUPAC_Name:
2,5,8,11,14,17-hexaoxaoctadecane

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane

# HET_ID:
PG6

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H26O6/c1-13-3-5-15-7-9-17-11-12-18-10-8-16-6-4-14-2/h3-12H2,1-2H3

# InChI_Key:
InChIKey=DMDPGPKXQDIQQG-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2580

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
266.3312

# Molecular_Weight_Mono:
266.172938564

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1D1J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.12

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
2.13e+00 g/l

# Primary_Accession_No:
DB02580

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
70931

# PubChem_Substance_ID:
46506612

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02566

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COCCOCCOCCOCCOCCOC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:17 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_10_Essentiality:
Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AAYG02000029

# Drug_Target_10_GenBank_ID_Protein:
153793979

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
RUMGNA_03254

# Drug_Target_10_Gene_Sequence:
>363 bp
TTGGAAGGAGTAACAGCTACAGATAAGGAAGACGGTAATCTGACAGATAAGATCCAAGTG
CTGAAGAACACCGTGAATAAAGAGGAAGCAGGAACCTATGAAGTGACATATAAGGTAACA
GACAGTCAAGGAGCAAGCACAATAAAGACGATCACAGTTACTGTGAGGGAAAAGAGTGCA
GATAAGCCTGCGGAACCTCAGAAGCCGAACAAGCCGGCTGACACAAAGCCTGGAAAACCA
AGTCAGCAGTCCGAATCGCCGAAGACAGCGGATATGTCTAATATTGGTTTGTTCGGATCT
ATGTTTGCAGGTTCGTCTGGATTACTGACAATGTTGCTGGGGAAAAGACGCAAAAAGAAA
TAA

# Drug_Target_10_General_Function:
Not Available

# Drug_Target_10_General_References:
Not Available

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
6819

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
37134.2

# Drug_Target_10_Name:
Putative uncharacterized protein

# Drug_Target_10_Number_of_Residues:
332

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF02645	DegV

# Drug_Target_10_Protein_Sequence:
>Putative uncharacterized protein
MYPGELSFRQNRKSKRYKNVFSSDTKCGILSNVVLKTTYNRWWKKKVWFGRKDMSYKVIV
DSCGEFTPEMKADGGFEHVALGIQIEDTQWTDDDSLKQEELLLKIAESTSCAKTSCPSPE
RYMESYHCDAERIYVVTLSAELSGSYNSAVLGKNLYEEEYGEKQIHVFNSRSASVGETLI
ALKVQQCEKAGMTFEEVVESVECYIEEQHTYFVLENLDTLRKNGRLTGIKSLVAGALNIK
PIMGSTPQGTICQKEKARGMKKALVKMADCVAADVVNAGDKILAIAHCNCEERAKEVQRL
LKERFAVKSSFIVDTSGISTVYANDGGIIVVV

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Not Available

# Drug_Target_10_SwissProt_ID:
A7B6P0

# Drug_Target_10_SwissProt_Name:
A7B6P0_RUMGN

# Drug_Target_10_Synonyms:
Not Available

# Drug_Target_10_Theoretical_pI:
6.96

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_11_Essentiality:
Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
BA000031

# Drug_Target_11_GenBank_ID_Protein:
28804983

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
VP2116

# Drug_Target_11_Gene_Sequence:
>150 bp
ATGGAAAAACGATCGAATCAAAGCGAAAGGATCGAAAAAAGAGGCGCTGGAAAGAAAATA
ATACACAGAGTTATCACCAATCTGTCGATCTCGCTAAATTTGCCCAAATGTGGATCTATG
TGTGGGCAAATTTGGGGCAAGGTGTGTTGA

# Drug_Target_11_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_11_General_References:
12620739	Makino K, Oshima K, Kurokawa K, Yokoyama K, Uda T, Tagomori K, Iijima Y, Najima M, Nakano M, Yamashita A, Kubota Y, Kimura S, Yasunaga T, Honda T, Shinagawa H, Hattori M, Iida T: Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet. 2003 Mar 1;361(9359):743-9.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
6820

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
24061.5

# Drug_Target_11_Name:
Putative uncharacterized protein VP2116

# Drug_Target_11_Number_of_Residues:
209

# Drug_Target_11_PDB_ID:
Not Available

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
Not Available

# Drug_Target_11_Protein_Sequence:
>Putative uncharacterized protein VP2116
MNIKLYYVHDPMCSWCWGYKPTIEKLKQQLPGVIQFEYVVGGLAPDTNLPMPPEMQQKLE
GIWKQIETQLGTKFNYDFWKLCTPVRSTYQSCRAVIAAGFQDSYEQMLEAIQHAYYLRAM
PPHEEATHLQLAKEIGLNVQQFKNDMDGTLLEGVFQDQLSLAKSLGVNSYPSLVLQINDA
YFPIEVDYLSTEPTLKLIRERIIENMSAQ

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Not Available

# Drug_Target_11_SwissProt_ID:
Q87MW5

# Drug_Target_11_SwissProt_Name:
Q87MW5_VIBPA

# Drug_Target_11_Synonyms:
Not Available

# Drug_Target_11_Theoretical_pI:
4.87

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasm, cytoskeleton

# Drug_Target_1_Chromosome_Location:
3

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L10678

# Drug_Target_1_GenBank_ID_Protein:
190388

# Drug_Target_1_GeneCard_ID:
PFN2

# Drug_Target_1_Gene_Name:
PFN2

# Drug_Target_1_Gene_Sequence:
>423 bp
ATGGCCGGTTGGCAGAGCTACGTGGATAACCTGATGTGCGATGGCTGCTGCCAGGAGGCC
GCCATTGTCGGCTACTGCGACGCCAAATACGTCTGGGCAGCCACGGCCGGGGGCGTCTTT
CAGAGCATTACGCCAATAGAAATAGATATGATTGTAGGAAAAGACCGGGAAGGTTTCTTT
ACCAACGGTTTGACTCTTGGCGCGAAGAAATGCTCAGTGATCAGAGATAGTCTATACGTC
GATGGTGACTGCACAATGGACATCCGGACAAAGAGTCAAGGTGGGGAGCCAACATACAAT
GTGGCTGTCGGCAGAGCTGGTAGAGCATTGGTTATAGTCATGGGAAAGGAAGGTGTCCAC
GGAGGCACACTTAACAAGAAAGCATATGAACTCGCTTTATACCTGAGGAGGTCTGATGTG
TAA

# Drug_Target_1_General_Function:
Involved in actin binding

# Drug_Target_1_General_References:
10600384	Nodelman IM, Bowman GD, Lindberg U, Schutt CE: X-ray structure determination of human profilin II: A comparative structural analysis of human profilins. J Mol Biol. 1999 Dec 17;294(5):1271-85.
11027290	Lambrechts A, Braun A, Jonckheere V, Aszodi A, Lanier LM, Robbens J, Van Colen I, Vandekerckhove J, Fassler R, Ampe C: Profilin II is alternatively spliced, resulting in profilin isoforms that are differentially expressed and have distinct biochemical properties. Mol Cell Biol. 2000 Nov;20(21):8209-19.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
18083107	Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
7758455	Gieselmann R, Kwiatkowski DJ, Janmey PA, Witke W: Distinct biochemical characteristics of the two human profilin isoforms. Eur J Biochem. 1995 May 1;229(3):621-8.
8365484	Honore B, Madsen P, Andersen AH, Leffers H: Cloning and expression of a novel human profilin variant, profilin II. FEBS Lett. 1993 Sep 13;330(2):151-5.

# Drug_Target_1_HGNC_ID:
GNC:8882

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6804

# Drug_Target_1_Locus:
3q25.1-q25.2

# Drug_Target_1_Molecular_Weight:
15046.2

# Drug_Target_1_Name:
Profilin-2

# Drug_Target_1_Number_of_Residues:
140

# Drug_Target_1_PDB_ID:
1D1J

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00235	Profilin

# Drug_Target_1_Protein_Sequence:
>Profilin-2
MAGWQSYVDNLMCDGCCQEAAIVGYCDAKYVWAATAGGVFQSITPIEIDMIVGKDREGFF
TNGLTLGAKKCSVIRDSLYVDGDCTMDIRTKSQGGEPTYNVAVGRAGRVLVFVMGKEGVH
GGGLNKKAYSMAKYLRDSGF

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Binds to actin and affects the structure of the cytoskeleton. At high concentrations, profilin prevents the polymerization of actin, whereas it enhances it at low concentrations. By binding to PIP2, it inhibits the formation of IP3 and DG

# Drug_Target_1_SwissProt_ID:
P35080

# Drug_Target_1_SwissProt_Name:
PROF2_HUMAN

# Drug_Target_1_Synonyms:
Profilin II

# Drug_Target_1_Theoretical_pI:
7.04

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
EF409421

# Drug_Target_2_GenBank_ID_Protein:
125719298

# Drug_Target_2_GeneCard_ID:
bpuJIR

# Drug_Target_2_Gene_Name:
bpuJIR

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Involved in endonuclease activity

# Drug_Target_2_General_References:
17392342	Sukackaite R, Lagunavicius A, Stankevicius K, Urbanke C, Venclovas C, Siksnys V: Restriction endonuclease BpuJI specific for the 5'-CCCGT sequence is related to the archaeal Holliday junction resolvase family. Nucleic Acids Res. 2007;35(7):2377-89. Epub 2007 Mar 28.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6811

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
53892.7

# Drug_Target_2_Name:
Restriction endonuclease R.BpuJI

# Drug_Target_2_Number_of_Residues:
462

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
>Restriction endonuclease R.BpuJI
MNYNPEEQFRCTIIRGKAKNMLDNLLPAYANIIDDICPCDKASFVKDFNNRLIEILGEET
TKKTLDNHRTEIAGKLFGMFYEDDEVIFPSGRTNKYIEDSDQPAFFKDICFKFQFPNGMD
KLDKVIEKVGAKIQIRQFPYILQVLLTADNNNIQLSKDDIAYYVLNSLQVLQGKIKPIEV
IEKIIEDRSNDITKKVRHPGKETSYSMQHIREQLNYLELANLIRIDGNLVKLNYREAENI
NYIAQFWGNKPEFNAYKYDFTSEDDKKSFFKDWQQYYSNVNSHKSFTTTVEALDVYPTKP
TYTIDKNALGDEGENLVLEYEKERVKLFDPSLVRKVVHLGKTKGLGYDIQSVVAEDGDFA
EFVKYIEVKSTKRVTVPNLDDPSWIDTINLTRNEWIAATQHKSSYYLYRVYFTPGLATMY
VINDPFTKNKDDILRAKPVSYRLDFSNKAVDFMVTEEKEEYR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
A3FMN7

# Drug_Target_2_SwissProt_Name:
A3FMN7_BACPU

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
5.32

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Periplasm (By similarity)

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AJ880678

# Drug_Target_3_GenBank_ID_Protein:
73661133

# Drug_Target_3_GeneCard_ID:
nir

# Drug_Target_3_Gene_Name:
nir

# Drug_Target_3_Gene_Sequence:
Not Available

# Drug_Target_3_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_3_General_References:
16500161	Tikhonova TV, Slutsky A, Antipov AN, Boyko KM, Polyakov KM, Sorokin DY, Zvyagilskaya RA, Popov VO: Molecular and catalytic properties of a novel cytochrome c nitrite reductase from nitrate-reducing haloalkaliphilic sulfur-oxidizing bacterium Thioalkalivibrio nitratireducens. Biochim Biophys Acta. 2006 Apr;1764(4):715-23. Epub 2006 Feb 9.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6812

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
62344.4

# Drug_Target_3_Name:
Eight-heme nitrite reductase

# Drug_Target_3_Number_of_Residues:
553

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02335	Cytochrom_C552

# Drug_Target_3_Protein_Sequence:
>Eight-heme nitrite reductase
MNDLNRLGRVGRWIAGAACLFLASAAHAEPGENLKPVDAMQCFDCHTQIEDMHTVGKHAT
VNCVHCHDATEHVETASSRRMGERPVTRMDLEACATCHTAQFNSFVEVRHESHPRLEKAT
PTSRSPMFDKLIAGHGFAFEHAEPRSHAFMLVDHFVVDRAYGGRFQFKNWQKVTDGMGAV
RGAWTVLTDADPESSDQRRFLSQTATAANPVCLNCKTQDHILDWAYMGDEHEAAKWSRTS
EVVEFARDLNHPLNCFMCHDPHSAGPRVVRDGLINAVVDRGLGTYPHDPVKSEQQGMTKV
TFQRGREDFRAIGLLDTADSNVMCAQCHVEYNCNPGYQLSDGSRVGMDDRRANHFFWANV
FDYKEAAQEIDFFDFRHATTGAALPKLQHPEAETFWGSVHERNGVACADCHMPKVQLENG
KVYTSHSQRTPRDMMGQACLNCHAEWTEDQALYAIDYIKNYTHGKIVKSEYWLAKMIDLF
PVAKRAGVSEDVLNQARELHYDAHLYWEWWTAENSVGFHNPDQARESLMTSISKSKEAVS
LLNDAIDAQVASR

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
1-28

# Drug_Target_3_Specific_Function:
Plays a role in nitrite reduction (By similarity)

# Drug_Target_3_SwissProt_ID:
Q5F2I3

# Drug_Target_3_SwissProt_Name:
Q5F2I3_9GAMM

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
6.35

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
BA000030

# Drug_Target_4_GenBank_ID_Protein:
29603637

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
SAV4671

# Drug_Target_4_Gene_Sequence:
>234 bp
GTGCCCCCTCAGGGAGCCCGTGGCACGATCGTGTCAGCTACCGGGTCCGGCAAAACGAGC
ATGGCCGCCGCGAGCACGCTGAACTGCTTCCCCGAAGGCCGGATCCTCGTGACCGTGCCG
ACCCTGGACCTGCTCGCACAGACCGCCCAGGCGTGGCGGGCAGTCGGCCACCACTCCCCC
ATGATCGCGGTGTGCTCGCTGGAGAACGACCCAGTGCTGAACGAGCGGACCTGA

# Drug_Target_4_General_Function:
Not Available

# Drug_Target_4_General_References:
11572948	Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H, Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M: Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12215-20. Epub 2001 Sep 25.
12692562	Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Omura S: Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol. 2003 May;21(5):526-31. Epub 2003 Apr 14.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6813

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
18159.8

# Drug_Target_4_Name:
Putative uncharacterized protein

# Drug_Target_4_Number_of_Residues:
169

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
Not Available

# Drug_Target_4_Protein_Sequence:
>Putative uncharacterized protein
MSTPTPDTDVEQVGLANTAFYEAMERGDFETLSSLWLTPADLGVDEEYHDPADAGVVSCV
HPGWPVLSGRGEVLRSYALIMANTEYIQFFLTDVHVSVTGDTALVTCTENILSGGPPPDD
SDELGPLVGQLVVATNVFRRTPDGWKLWSHHASPVLAETGAEEGDESPD

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
Q82EE4

# Drug_Target_4_SwissProt_Name:
Q82EE4_STRAW

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
3.80

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_5_Essentiality:
Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AE017180

# Drug_Target_5_GenBank_ID_Protein:
41152665

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
GSU1007

# Drug_Target_5_Gene_Sequence:
>1338 bp
ATGGAAGAAGTTTGGCTCCAGGCACAATCCAATCTCGCTAAGGTTCTCACACATCAGACC
TTTAACACCTGGATCGAACCGATCAAGTATCTCGGATCCAAGAAGAATGTGCTGCTGCTG
GAAGCCCCGAACCAGTTCGTCAGGGACCGGGTAAGCGAAAGCTATCTTCCCATGATTCTC
GAATCGGTTCAATCGCTTACCGATTCCCAGACCAAGATCGAACTTCTGATCGCAAAGCCC
AAAACGGAAAAACCCAAACAGCCTGCGGCCTCTGAGGTCACCGCCGCGGAACCGGAAGCC
TGTTCGGGGCCCGATCACTCAACCAACCTGAACCCCAAGTACACCTTCGACACGTTCGTC
TGCGGCGGCAGCAACCAGTTCGCTCACGCGGCGGCCCAGTCGGTGGCGAACAGCCCGGCC
GGCAAGTACAATCCCCTTTTCATATACGGTGGCGTGGGACTGGGTAAAACCCACCTCCTC
AACGCAATCGGCAACCATGTGCTGTCGGTGAACCGCAAGGCACGGATCTGTTTCTACACG
TCGGAAAAATTCATGAACGAACTCATCAACTGCCTGCGGTACCAGAAGATGGATCAGTTC
AGAAACAAGTTCCGTAAGATGGACATTCTTCTCATCGACGACATCCAGTTCATCGCCGGC
AAGGAACGGACCCAGGAGGAGTTTTTCCACACCTTCAACTCGCTCTACGAATCCCACAAG
CAGATCGTAGTGACGTCCGACAAGTTCCCCAAGGATATTCCCGGCCTGGAAGAGCGCCTC
CGCTCACGTTTCGAGTGGGGCCTCATCGCCGATATCCAGGCGCCCGACACGGAAACCAAG
GTAGCGATCCTGCGCAAGAAGGCGGATGCGGACCATATCTCGCTCCCCGACGATGTGGCC
CTGTTTCTGGCATCCAGCTCAACAACCAACGTGCGGGAACTGGAAGGAATGCTCATCAGA
CTCGGTGCCGTTTCGAGCCTGACCGGCAAGAACATCACCCTCGACATGGCACGGGAAGTC
CTCAAGGACATCATTGTGGACAAGTCGAAGGAAATAACGGTTGAGATGATCCAGAAATTC
GTGGCCGAACACTTCAGCCTCAAGGTGGCTGATCTCAAATCGGACAAGCGGCTCAAGGCG
CTGGTGATACCACGCCAGATTGCCATATTCCTGTGCCGTGATCTTACCAAATCTTCATAT
CCGGAGATCGGTGAACGGTTCGGCGGCAAAGATCATTCAACCATCATCCACTCGGTGAAA
AAGGTGGAAAAGCTCCTCAGTCAGGATTTCGAACTCAGAAACACCGTCGACACCCTGAGG
AAGGGGCTGTTGAGCTGA

# Drug_Target_5_General_Function:
Signal transduction mechanisms

# Drug_Target_5_General_References:
14671304	Methe BA, Nelson KE, Eisen JA, Paulsen IT, Nelson W, Heidelberg JF, Wu D, Wu M, Ward N, Beanan MJ, Dodson RJ, Madupu R, Brinkac LM, Daugherty SC, DeBoy RT, Durkin AS, Gwinn M, Kolonay JF, Sullivan SA, Haft DH, Selengut J, Davidsen TM, Zafar N, White O, Tran B, Romero C, Forberger HA, Weidman J, Khouri H, Feldblyum TV, Utterback TR, Van Aken SE, Lovley DR, Fraser CM: Genome of Geobacter sulfurreducens: metal reduction in subsurface environments. Science. 2003 Dec 12;302(5652):1967-9.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6814

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
60196.1

# Drug_Target_5_Name:
GAF domain/HD domain protein

# Drug_Target_5_Number_of_Residues:
550

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01590	GAF
PF01966	HD

# Drug_Target_5_Protein_Sequence:
>GAF domain/HD domain protein
MTGTYTELIEGSERLSGLTDVDEVIKDLSRLLRKLVKTRWIAVYFFDRERRDFAPARSTG
LPASFLPVFREMPLAPDKIPLLKSMLRKRQHLMLTDPGSSDLLTPKLRKLLRNLCVLAVP
MVVRTQVIGAVFMARTRDNPPFSDAETAIIRDLVSHAALVVSHMQLFDESLDMALDLAGR
IDVILTIDEINKAISSSLSRERIMETAMAQVERITGCEFVAILQAENGGLKVMSSHASGL
EIPAALRPGAPLSLAGCTAWTAFRTGRSASIADLADTRKPGTVSRTLLAAGIRSLLAIPL
MSRDQVKGVLLLGDTEPDKFARGETFTIEKIASQMAVALENARLYEDMRSLFFNTVSSLA
NAIDAKSPWTKGHSERVMHISTRIAKEMGLSEQEVEQIRLGGLLHDIGKIGVIEALLEKP
ALLSEDEFPPMRLHPEKGVAILAPIAQLKEVLPVILYHHERLDGSGYPEGLTGDHIPLGA
RIVAVADSFDAMVSERPYKHANTLTEALEELRAGAGSQFDPVVVECFARYVKRVMGKGGG
NTPGVLWEAA

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q74EF5

# Drug_Target_5_SwissProt_Name:
Q74EF5_GEOSL

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
6.80

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
CP001219

# Drug_Target_6_GenBank_ID_Protein:
218519790

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
AFE_1514

# Drug_Target_6_Gene_Sequence:
>1098 bp
ATGAAAATCACCATAGATCGTGAAGATCTTCTCCCCATCCTGGCGAATATGGCCAATATT
GCCGACCGGCGCCCGGTACAACCAATTCTGGCCCATGTCCTTATCGAAGCCGCAGGCCAA
CACTGCCGCTTCGTCGCTACCGATCTGGAAGTCCAGCTTTCCGCCGACCTGGATCACCCG
GTAGATGCGCCGGGCACTTGCGCCGTCCCCGCTCGCAAACTCTATGACATCTGTCGGGCG
TTACCCGAACACACCCCCATAGAATTTCATAAAGACGGCGAAAAGCTGCTCCTGAAGGCC
GCCAAGAGCCGCTTTACCCTGCACATATTACCCGCCGATCAATTTCCGTACCTCAGTACC
CACAGCAGCCTCTGTCAGGGTAACGGCAATGCCAAAACCTTTCGCGAAGCGCTCGCCGTC
GTCGCCAACACCATGGCACAGAACGACGCAAGGCTTTTTCTGAACGGCGTCCTCATCGAG
GTGGAAGGTCAGGAGCTGCGTCTCGTAGCCACCGACGGTCATCGTCTGGCCATGATGACC
CTGCCTTTTGCCAGCAGCCTGGAAAGCGGAAGCTACCAGGCCATACTGCCGCGCAAAGCC
GTCCTCGAACTACTGCGGATTCTCGATGACGGCGACATCGTTCTGGAAATGTCGGATGCC
AGCTTTCTGCTCAATGATGGTACACAGCAGTTCGCCTGCAAGCTCATCGACGCCAAATAT
CCCGATTACCGCCGGGTCATCCCCCAGGGACACCCCCGCTTCGCCATACTGGACCGCCAG
GCCTTCAAAAGTGCCTTGCAGCAGAGCGACGTTCTGGTCAGCGACCGTAATCCGACCACC
CATCTTCATCTGGAAAACGACCAGATGACCCTGCGCAGCCGCAATGAGGAGCAGGAGGAA
GGCGAAATCCAGATTCCCGTCGAGTATCAGGGTGACACCCTGGATATCGCTTTCAACAGC
CGCTATCTGACGGACACGACCCAGATATTCCCCCAGGAAAGTTTGCGGATGCGGGTCAAG
GACAGCGACAGCAGCGCCGTTTTCACCCCGGTAGACAGCAATAATCCCCTGTATATCATC
ATGCCCGTTCGTCTTTGA

# Drug_Target_6_General_Function:
Not Available

# Drug_Target_6_General_References:
19077236	Valdes J, Pedroso I, Quatrini R, Dodson RJ, Tettelin H, Blake R 2nd, Eisen JA, Holmes DS: Acidithiobacillus ferrooxidans metabolism: from genome sequence to industrial applications. BMC Genomics. 2008 Dec 11;9:597.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6815

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
17701.5

# Drug_Target_6_Name:
Putative uncharacterized protein

# Drug_Target_6_Number_of_Residues:
155

# Drug_Target_6_PDB_ID:
Not Available

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF03270	DUF269

# Drug_Target_6_Protein_Sequence:
>Putative uncharacterized protein
MPENTAMAALLPEESLFFRELVKQWRAQDSYGTWEKKSDMELLAPYVLDKEQRRAIPIIG
DPDPEILWRVELFYNAVGLATERASGVMVSPMMKMSHEGFGRMVLIAGRLIVVNKQLRDV
HRFGFPSMEKLAEEGDKLVAGALEMIEKFPEVARF

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
B7JA91

# Drug_Target_6_SwissProt_Name:
B7JA91_ACIF2

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
5.08

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_7_Essentiality:
Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
CP000124

# Drug_Target_7_GenBank_ID_Protein:
76580589

# Drug_Target_7_GeneCard_ID:
gpmA

# Drug_Target_7_Gene_Name:
gpmA

# Drug_Target_7_Gene_Sequence:
>999 bp
ATGTACACGCAATCCCTCGACATCCCCGGCAACATCGCGCCGATCGATGCCGCCGCCGAT
TCGCCCGAACAGGCAGGATTCGATGCCGCCATCGCCGCCGACGGCAAGATCGAACCGCAG
GACTGGATGCCCGACGCTTACCGCAAGACGCTCGTGCGGCAGATTTCGCAGCACGCGCAC
TCGGAAGTCGTCGGCATGCTGCCGGAAGGCAACTGGATCACGCGCGCCCCGAGCCTCAAG
CGCAAGGCGATCCTGCTCGCGAAGGTCCAGGACGAAGCCGGTCACGGCCTCTATCTATAT
AGCGCCGCGGAAACGCTCGGCGTATCGCGCGATGCGCTGATCGACGCGCTGCACGCGGGC
AAAGCCAAGTATTCGAGCATCTTCAATTACCCCACCCTCACGTGGGCGGATGTCGGCGTG
ATCGGCTGGCTCGTCGACGGCGCGGCGATCATGAACCAGGTTCCGCTCTGCCGCTGCACG
TACGGCCCGTATGCGCGCGCGATGATCCGCGTCTGCAAGGAGGAATCGTTCCATCAGCGG
CAAGGCTTCGACGCGCTGCTCGCGATGATGAAGGGCACCGACGCGCAGCGCGCGATGGTC
CAGGAAGCCGTGGACCGCTGGTGGTGGCCCGTGCTGATGATGTTCGGGCCGCCCGACGCC
GATTCCGTGCACAGCAACCAGTCGGCCAAATGGGGGATCAAGCGGATTTCGAACGACGAC
CTGCGGCAGAAATTCGTCGACGCGACGGTCGAGCAGGCGAAGGTGCTCGGCGTCACGCTG
CCCGATCCGGACCTCAAGTGGAACGACGCCCGCGGCCATTTCGATTACGGCGCGCTCGAC
TGGGACGAATTCTGGCGCGTCGTCAACGGCGACGGCCCGTGCAACAAGGAGCGCCTCGCG
ACCCGCGTGAAGGCTCACGAAAACGGCGCGTGGGTTCGCGACGCCGCGCTCGCGCACGAG
GAAAAGCGCCGCCGTCGCGCGCAGCAACAAGCGGCCTAA

# Drug_Target_7_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_7_General_References:
Not Available

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
6816

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
27892.5

# Drug_Target_7_Name:
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase

# Drug_Target_7_Number_of_Residues:
249

# Drug_Target_7_PDB_ID:
Not Available

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00300	PGAM

# Drug_Target_7_Protein_Sequence:
>2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MYKLVLIRHGESTWNKENRFTGWVDVDLTEQGNREARQAGQLLKEAGYTFDIAYTSVLKR
AIRTLWHVQDQMDLMYVPVVHSWRLNERHYGALSGLNKAETAAKYGDEQVLVWRRSYDTP
PPALEPGDERAPYADPRYAKVPREQLPLTECLKDTVARVLPLWNESIAPAVKAGKQVLIA
AHGNSLRALIKYLDGISDADIVGLNIPNGVPLVYELDESLTPIRHYYLGDQEAIAKAQAA
VAQQGKSAA

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglycerate (By similarity)

# Drug_Target_7_SwissProt_ID:
Q3JWH7

# Drug_Target_7_SwissProt_Name:
GPMA_BURP1

# Drug_Target_7_Synonyms:
BPG-dependent PGAM
PGAM
Phosphoglyceromutase
dPGM

# Drug_Target_7_Theoretical_pI:
6.80

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_8_Essentiality:
Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AL590842

# Drug_Target_8_GenBank_ID_Protein:
115345833

# Drug_Target_8_GeneCard_ID:
purA

# Drug_Target_8_Gene_Name:
purA

# Drug_Target_8_Gene_Sequence:
>993 bp
ATGAAAAAACAATTTATCCAAAAACAACAACAAATCAGCTTCGTAAAATCATTCTTTTCC
CGCCAATTAGAGCAACAACTTGGCTTGATCGAAGTCCAGGCTCCTATTTTGAGCCGTGTG
GGTGATGGAACCCAAGATAACCTTTCTGGTTCTGAGAAAGCGGTACAGGTAAAAGTTAAG
TCATTGCCGGATTCAACTTTTGAAGTTGTACATTCATTAGCGAAGTGGAAACGTAAAACC
TTAGGGCGTTTTGATTTTGGTGCTGACCAAGGGGTGTATACCCATATGAAAGCATTGCGC
CCAGATGAAGATCGCCTGAGTGCTATTCATTCTGTATATGTAGATCAGTGGGATTGGGAA
CGGGTTATGGGGGACGGTGAACGTAACCTGGCTTACCTGAAATCGACTGTTAACAAGATT
TATGCAGCGATTAAAGAAACTGAAGCGGCGATCAGTGCTGAGTTTGGTGTGAAGCCTTTC
CTGCCGGATCATATTCAGTTTATCCACAGTGAAAGCCTGCGGGCCAGATTCCCTGATTTA
GATGCTAAAGGCCGTGAACGTGCAATTGCCAAAGAGTTAGGTGCTGTCTTCCTTATAGGG
ATTGGTGGCAAATTGGCAGATGGTCAATCCCATGATGTTCGTGCGCCAGATTATGATGAT
TGGACCTCTCCGAGTGCGGAAGGTTTCTCTGGATTAAACGGCGACATTATTGTCTGGAAC
CCAATATTGGAAGATGCCTTTGAGATATCTTCTATGGGAATTCGTGTTGATGCCGAAGCT
CTTAAGCGTCAGTTAGCCCTGACTGGCGATGAAGACCGCTTGGAACTGGAATGGCATCAA
TCACTGTTGCGCGGTGAAATGCCACAAACTATCGGGGGAGGTATTGGTCAGTCCCGCTTA
GTGATGTTATTGCTGCAGAAACAACATATTGGTCAGGTGCAATGTGGTGTTTGGGGCCCT
GAAATCAGCGAGAAAGTTGATGGCCTGCTGTAA

# Drug_Target_8_General_Function:
Nucleotide transport and metabolism

# Drug_Target_8_General_References:
11586360	Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, Baker S, Basham D, Bentley SD, Brooks K, Cerdeno-Tarraga AM, Chillingworth T, Cronin A, Davies RM, Davis P, Dougan G, Feltwell T, Hamlin N, Holroyd S, Jagels K, Karlyshev AV, Leather S, Moule S, Oyston PC, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG: Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 2001 Oct 4;413(6855):523-7.
12142430	Deng W, Burland V, Plunkett G 3rd, Boutin A, Mayhew GF, Liss P, Perna NT, Rose DJ, Mau B, Zhou S, Schwartz DC, Fetherston JD, Lindler LE, Brubaker RR, Plano GV, Straley SC, McDonough KA, Nilles ML, Matson JS, Blattner FR, Perry RD: Genome sequence of Yersinia pestis KIM. J Bacteriol. 2002 Aug;184(16):4601-11.
15368893	Song Y, Tong Z, Wang J, Wang L, Guo Z, Han Y, Zhang J, Pei D, Zhou D, Qin H, Pang X, Han Y, Zhai J, Li M, Cui B, Qi Z, Jin L, Dai R, Chen F, Li S, Ye C, Du Z, Lin W, Wang J, Yu J, Yang H, Wang J, Huang P, Yang R: Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res. 2004 Jun 30;11(3):179-97.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
6817

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
47277.7

# Drug_Target_8_Name:
Adenylosuccinate synthetase

# Drug_Target_8_Number_of_Residues:
432

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00709	Adenylsucc_synt

# Drug_Target_8_Protein_Sequence:
>Adenylosuccinate synthetase
MGKNVVVLGTQWGDEGKGKVVDLLTERAKYVVRYQGGHNAGHTLVINGEKTVLHLIPSGI
LRENVISIIGNGVVLAPDALMKEMTELEARGVPVRERLLLSEACPLILPYHVALDNAREK
ARGAKAIGTTGRGIGPAYEDKVARRGLRVSDLFNKETFAIKLKEIVEYHNFQLVHYYKEA
AVDYQKVLDDVLAIADILTAMVVDVSELLDNARKQGELIMFEGAQGTLLDIDHGTYPYVT
SSNTTAGGVATGSGLGPRYVDYVLGIVKAYSTRVGAGPFPTELNDETGEFLRKQGNEYGA
TTGRSRRTGWLDIVAVRRAVQINSLSGFCMTKLDVLDGLKEVKLCVGYRMPDGREVDTTP
LAAEGWEGIEPIYETMPGWSETTFGVKEHSKLPQAALNYIQRVEELTGVPIDIISTGPDR
DETMILRDPFDA

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Plays an important role in the de novo pathway of purine nucleotide biosynthesis

# Drug_Target_8_SwissProt_ID:
Q8ZIV7

# Drug_Target_8_SwissProt_Name:
PURA_YERPE

# Drug_Target_8_Synonyms:
AMPSase
AdSS
IMP--aspartate ligase

# Drug_Target_8_Theoretical_pI:
5.24

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_9_Essentiality:
Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
CP000252

# Drug_Target_9_GenBank_ID_Protein:
85720937

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
SYNAS_17590

# Drug_Target_9_Gene_Sequence:
>1374 bp
GTGGACAGGTATTGTATAGTGGATAATCTCTGGGAAGAAAGTATTAAAATCATTAAGGAA
AAAATTAGCCCACAGAATTTTGAAACCTGGATTCGTCCGCTTAAAGTGGTCTCTCTCGAA
GGGAATCATGCCAGCCTGTCGGTACCGAACAAGTTTTTTAAAGACTGGTTGACTGAAAAC
TATCGGGATGTCATTTCCGACGCCGTATCCTCATCGGCTGGAAAAGACTATGCGATTGAT
TTTGTTATCCTTCAGGAATCTGAAAAAAATTCCCGCTCCGCTCACCCGGCGAGAAAGAAA
AAAATCATCGAGCAGATCCCCCAAGAAAAAATTCGTCCCAAAATTCATCCCACGTTAAAC
CCAAATTACAGTTTTGAACGTTTCGTTGTGGGCTCATCCAATCAGTTCGCCCATGCGGCA
GCGGTTGCCGTTGCCGAACAGCCGGCCAAAAATTACAATCCTCTGTTCATCTACGGAGGC
GTGGGGCTGGGTAAGACGCATCTCCTGAATGCCATCGGACTGCTGAGCATGTCCATCTAT
CCCGATATGAACGTGGTCTACGTCTCCGCGGAAGAGTTCATGAACGAACTGATTCTCTCC
ATCCGCTACGACAAGATGCCTCAGTTCCGGGAAAAGTTCCGCAACATCGACTGCCTTTTG
ATGGATGATATTCAGTTTATTGCCGGAAAGGAGCGAACACAGGAAGAATTCTTTCACACC
TTCAACACGCTTCATGATTCCGGAAAACAGATCGTCGTCACAAGCGACAAATTTCCCAAG
GACATCCCGAACCTGGAAGGCCGCCTCCGTTCCCGTTTTGAGTGGGGTCTGATCGCCGAT
ATCCAGCCGCCGGAAATTGAAACCAAAATTGCCATCCTGGAAAAAAAGGCCCAGGAAAAC
AATATTCATATCCCGACCAATGTGGCCTATTACATCTCTTCCCATGCCGAATCCAACATC
CGCGAGCTGGAAGGTTTTCTCGTCCGTATTGCCGCCTATTCCTCGGTTACGGGAAGAAAC
ATCGATCTGGATCTGGTCAAGGAAGTTCTGAAAGACATCATCAAGCATCGGGAATCCGAC
GAAATTTCCTTCGAAGAAATTCTCAAGGCGGTCGCTGCCCGATATAACCTGAAAATCGCT
GATATCAAGTCGCAGAGCAAAAACAAGAACATCGCCATGGCGAGGCAGGTAACGATGTAC
ATGGCCCGGAAACTGACCGGAAGCTCTTTTCCGGACATCGGAGAAAAAATCGGGGGAAGG
GATCATTCCACAGTTATCTACGCCAACAATAAAATCCGTAAACTTCTGGAGACAGATTCC
AGGTTGAAAGCCACGCTCCAGGAAATCGAAGATCAACTCCTCAAGAAAAACTAA

# Drug_Target_9_General_Function:
Not Available

# Drug_Target_9_General_References:
Not Available

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
6818

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
17243.4

# Drug_Target_9_Name:
Hypothetical cytosolic protein

# Drug_Target_9_Number_of_Residues:
157

# Drug_Target_9_PDB_ID:
Not Available

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
Not Available

# Drug_Target_9_Protein_Sequence:
>Hypothetical cytosolic protein
MDEKPAITKIISGGQTGADRAALDFAIKHHIPYGGWVPKGRLAEGGRVPETYQLQEMPTS
DYSKRTEKNVLDSDGTLIISHGILKGGSALTEFFAEQYKKPCLHIDLDRISIEDAATLIN
SWTVSHHIQVLNIAGPRAGKDPEIYQATMDLLEVFLA

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
Q2LU76

# Drug_Target_9_SwissProt_Name:
Q2LU76_SYNAS

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
5.92

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB02580
